Revolution Medicines, Inc. (RVMD) Technical Analysis & Indicators
Revolution Medicines, Inc. (RVMD) — Price $188.72 (closing price, October 28, 2026) — Healthcare — Biotechnology — NASDAQ
Latest reported results:
Technical analysis of Revolution Medicines, Inc. (RVMD): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Revolution Medicines, Inc. is a precision oncology firm operating in the clinical development stage, dedicated to creating innovative treatments that target novel pathways crucial for RAS-driven cancers. Its pipeline includes several promising drug candidates: RMC-4630, an SHP2 inhibitor, is currently undergoing Phase 1/2 clinical trials for various solid tumors, such as gynecological and colorectal cancers.